Products
B2B Zone
5th Gene Therapy Immunogenicity Summit 2024
5th Gene Therapy Immunogenicity Summit 2024
Conferences

5th Gene Therapy Immunogenicity Summit 2024

By

Hanson Wade

2 Followers
20 Aug 2024 - 22 Aug 2024
Free Registration

Event Details

5th Gene Therapy Immunogenicity Summit 2024

The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck 'here and now'.

The 5th Gene Therapy Immunogenicity Summit is returning to Boston this August, bringing together 100+ immunogenicity experts responsible for predicting, measuring, and mitigating immune response. Join your colleagues as they share their learnings and gain key insights on:

* Effective approaches to promote AAV safety whilst maintaining efficacy
* Preventing the bottlenecks of the potential slowdown of gene therapy development
* Access specific, case-study-led examples across immunogenicity and ask the big-hitting immunology questions to your peers actively working in the space to make clinically safe and effective gene therapies a reality.
* Predicting and mitigating against complement activation and other toxicity issues with Ask Bio, Takeda, and Novartis
* Validating novel Immunoassays, bioanalytical and biodistribution technology with Astellas Gene Therapies and Boehringer Ingelheim
* Understanding possible risks around exacerbation of both the innate and adaptive immune response with Roche and Tenaya Therapeutics
* Exploring the practicalities of AAV redosing through an immunology lens with the University of Indiana and Adolore Biotherapeutics
* Examine the immunogenicity risks specific to gene editing approached as momentum in the field increases with CRISPR and Modalis Therapeutics


URLs:
Brochure: https://go.evvnt.com/2453359-0?pid=10018
Website: https://go.evvnt.com/2453359-1?pid=10018
Tickets: https://go.evvnt.com/2453359-2?pid=10018

Prices:
Conference + Workshop Day - Drug Developer: USD 4197.00,
Conference + Workshop Day - Solution Provider: USD 5097.00,
Conference + Workshop Day - Academic and Not For Profit: USD 3597.00,
Conference Only - Drug Developer: USD 2999.00,
Conference Only - Solution Provider: USD 3699.00,
Conference Only - Academic and Not For Profit: USD 2599.00

Speakers: Alison Johnson | Principal Scientist | Boehringer Ingelheim, Bala Medicherla | Head, Bioanalytics | Astellas Gene Therapies, Boris Gorovits | Vice President - Non-Clinical and Clinical Bioanalysis | Regeneron, Gretchen Argast | Sr. Director, Translational Medicine | Tenaya Therapeutics, Helene Haegel | Principal Scientist, Immunosafety | Roche, Kelley Penraat | Director - Translational Medicine | Novartis AG, Kruti Patel | Associate Director - Adeno- Associated Virus and Immunology | Solid Biosciences, Lakshmi Raj | Senior Principal Scientist | Novartis AG, Lalit Kumar | Director - Clinical Bioanalytics and Translational Science | Beam Therapeutics, Li Ou | Vice President - Research | Avirmax Inc., Lingzhi Zhao | Vice President | NeuShen Therapeutics, Naro Biswas | Assistant Professor | University of Indiana Medical School, Qing Zhou | Director | Abbvie, Rebecca Xicluna | Senior Scientist | Roche, Roelof Rongen | Chief Executive Officer | Adolore BioTherapeutics, Shari Gordon | Senior Director of Immunology | AskBio, Swati Gupta | Executive Director | Abbvie, Tetsuya Yamagata | Scientific Advisory and Chief Scientific Officer | Modalis Therapeutics, Xiaobin Zhang | Group Lead Nonclinical Immunogenicity Team | Takeda, Zifeng Mai | Clinical Pharmacology Lead, Senior Manager | CRISPR Therapeutics

Entry Fees

Free Registration

Categories

Event Frequency

One Time

Event Timings

(GMT-4:00) Eastern Time (US and Canada)
08:30 AM - 04:00 PM (Aug 20, Aug 21, Aug 22) (Public)

Speakers

Alison Johnson
Alison Johnson
Principal Scientist | Boehringer Ingelheim
Bala Medicherla
Bala Medicherla
Head, Bioanalytics | Astellas Gene Therapies
Boris Gorovits
Boris Gorovits
Vice President - Non-Clinical and Clinical Bioanalysis | Regeneron
Gretchen Argast
Gretchen Argast
Sr. Director, Translational Medicine | Tenaya Therapeutics

Organizer

Comments on 5th Gene Therapy Immunogenicity Summit 2024

You must to write a comment.

Peoples Interested in Visit

0 Peoples Interested to Visit

Event Location

The Westin Boston Seaport District
425, Summer Street, D Street / West Broadway, Boston ,
Suffolk County 02210, Massachusetts, United States
Official Link :

More Events By Organizer

4th mRNA-Based Therapeutics Summit
4th mRNA-Based Therapeutics Summit
29
Jul
2024

4th mRNA-Based Therapeutics Summit

Suffolk County, United States
Free
Conferences
4th Induced Proximity-Based Drug Discovery Summit
4th Induced Proximity-Based Drug Discovery Summit
23
Jul
2024
Free
Conferences
5th Gamma Delta T Therapies Summit 2024
5th Gamma Delta T Therapies Summit 2024
29
Jul
2024
Free
Conferences
Women's Health Therapeutics And Diagnostics Summit
Women's Health Therapeutics And Diagnostics Summit
23
Jul
2024
Free
Conferences
ESG in Manufacturing Summit 2024
ESG in Manufacturing Summit 2024
29
Jul
2024
Free
Conferences
5th Optimizing Hybrid Clinical Trials Summit 2024
5th Optimizing Hybrid Clinical Trials Summit 2024
11
Sep
2024
Free
Conferences

Similar Events

6th Gene Therapy for Rare Disorders 2023
6th Gene Therapy for Rare Disorders 2023
27
Jun
2023
Free
Conferences
13th World Clinical Biomarkers and CDx Boston 2023
13th World Clinical Biomarkers and CDx Boston 2023
05
Sep
2023
Free
Conferences
Sana Symposium 2023
Sana Symposium 2023
26
Oct
2023
Free
Conferences
2nd Liquid Biopsy Surveillance and Early Detection Summit
2nd Liquid Biopsy Surveillance and Early Detection Summit
07
Nov
2023
Free
Conferences
Benefits of Signin
  • Publish Your Event for Free
  • Find Upcoming Events Near By
  • Grow Your B2B Network
  • Fix B2B Meeting Online/Event
  • Showcase Products to Right People